EA200800203A1 - Замещенные изотопами ингибиторы протонного насоса - Google Patents
Замещенные изотопами ингибиторы протонного насосаInfo
- Publication number
- EA200800203A1 EA200800203A1 EA200800203A EA200800203A EA200800203A1 EA 200800203 A1 EA200800203 A1 EA 200800203A1 EA 200800203 A EA200800203 A EA 200800203A EA 200800203 A EA200800203 A EA 200800203A EA 200800203 A1 EA200800203 A1 EA 200800203A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- isomotoped
- inhibitors
- proton pump
- formula
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Abstract
Настоящее изобретение относится к бензимидазолам формулы (1) и фармацевтическим композициям, включающим такие соединения, а также к промежуточным соединениям формулы (2 или 3).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05106868 | 2005-07-26 | ||
PCT/EP2006/064666 WO2007012650A1 (en) | 2005-07-26 | 2006-07-26 | Isotopically substituted proton pump inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200800203A1 true EA200800203A1 (ru) | 2008-08-29 |
EA016814B1 EA016814B1 (ru) | 2012-07-30 |
Family
ID=35734406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200800203A EA016814B1 (ru) | 2005-07-26 | 2006-07-26 | Замещенные изотопами ингибиторы протонного насоса |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1910293A1 (ru) |
JP (1) | JP5448448B2 (ru) |
KR (1) | KR101358509B1 (ru) |
CN (2) | CN101268051B (ru) |
AR (1) | AR054584A1 (ru) |
AU (1) | AU2006274036B2 (ru) |
BR (1) | BRPI0614039A2 (ru) |
CA (1) | CA2615670C (ru) |
EA (1) | EA016814B1 (ru) |
HK (2) | HK1125098A1 (ru) |
IL (1) | IL188773A (ru) |
MX (1) | MX2008000901A (ru) |
NO (1) | NO20080839L (ru) |
NZ (1) | NZ565078A (ru) |
TW (1) | TWI394750B (ru) |
WO (1) | WO2007012650A1 (ru) |
ZA (1) | ZA200800303B (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007012651A1 (en) * | 2005-07-26 | 2007-02-01 | Nycomed Gmbh | Isotopically substituted pantoprazole |
CA2624179A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
WO2008127640A2 (en) * | 2007-04-11 | 2008-10-23 | Auspex Pharmaceuticals, Inc. | Substituted benzimidazoles |
US20080255200A1 (en) * | 2007-04-11 | 2008-10-16 | Auspex Pharmaceuticals, Inc. | Substituted benzimidazoles |
JP5714031B2 (ja) | 2010-02-12 | 2015-05-07 | エステヴェ キミカ, エス.エー. | エソメプラゾールナトリウムのナトリウム塩の調製方法 |
CN104530003A (zh) * | 2014-06-10 | 2015-04-22 | 广东东阳光药业有限公司 | 吡啶甲基亚磺酰基-1h-苯并咪唑类化合物的盐的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
JPH0643426B2 (ja) * | 1986-07-25 | 1994-06-08 | 東京田辺製薬株式会社 | イミダゾ〔4,5−b〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 |
DE69535592T2 (de) * | 1994-03-25 | 2008-06-12 | Isotechnika, Inc., Edmonton | Verbesserung der effektivität von arzneimitteln duren deuterierung |
US6334997B1 (en) * | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
US6884429B2 (en) * | 1997-09-05 | 2005-04-26 | Isotechnika International Inc. | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
NO309305B1 (no) * | 1999-02-19 | 2001-01-15 | Norsk Hydro As | Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater |
DE10123129A1 (de) * | 2001-05-02 | 2002-11-14 | Berolina Drug Dev Ab Svedala | Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel |
DE10162121A1 (de) * | 2001-12-12 | 2003-06-18 | Berolina Drug Dev Ab Svedala | Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel |
WO2007012651A1 (en) * | 2005-07-26 | 2007-02-01 | Nycomed Gmbh | Isotopically substituted pantoprazole |
-
2006
- 2006-07-26 AU AU2006274036A patent/AU2006274036B2/en not_active Ceased
- 2006-07-26 NZ NZ565078A patent/NZ565078A/en not_active IP Right Cessation
- 2006-07-26 CN CN2006800345034A patent/CN101268051B/zh not_active Expired - Fee Related
- 2006-07-26 WO PCT/EP2006/064666 patent/WO2007012650A1/en active Application Filing
- 2006-07-26 MX MX2008000901A patent/MX2008000901A/es active IP Right Grant
- 2006-07-26 CA CA2615670A patent/CA2615670C/en not_active Expired - Fee Related
- 2006-07-26 EP EP06764258A patent/EP1910293A1/en not_active Withdrawn
- 2006-07-26 JP JP2008523354A patent/JP5448448B2/ja not_active Expired - Fee Related
- 2006-07-26 EA EA200800203A patent/EA016814B1/ru not_active IP Right Cessation
- 2006-07-26 AR ARP060103224A patent/AR054584A1/es unknown
- 2006-07-26 KR KR1020087003989A patent/KR101358509B1/ko not_active IP Right Cessation
- 2006-07-26 BR BRPI0614039-4A patent/BRPI0614039A2/pt not_active IP Right Cessation
- 2006-07-26 TW TW095127340A patent/TWI394750B/zh not_active IP Right Cessation
- 2006-07-26 CN CN2011100224850A patent/CN102134232B/zh not_active Expired - Fee Related
-
2008
- 2008-01-10 ZA ZA2008/00303A patent/ZA200800303B/en unknown
- 2008-01-15 IL IL188773A patent/IL188773A/en not_active IP Right Cessation
- 2008-02-18 NO NO20080839A patent/NO20080839L/no not_active Application Discontinuation
-
2009
- 2009-03-12 HK HK09102398.5A patent/HK1125098A1/xx not_active IP Right Cessation
-
2012
- 2012-01-18 HK HK12100603.5A patent/HK1160126A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101268051A (zh) | 2008-09-17 |
CN102134232A (zh) | 2011-07-27 |
CN102134232B (zh) | 2012-11-21 |
TWI394750B (zh) | 2013-05-01 |
HK1125098A1 (en) | 2009-07-31 |
TW200714596A (en) | 2007-04-16 |
WO2007012650A1 (en) | 2007-02-01 |
AR054584A1 (es) | 2007-06-27 |
EP1910293A1 (en) | 2008-04-16 |
IL188773A (en) | 2014-02-27 |
AU2006274036B2 (en) | 2012-05-24 |
CA2615670C (en) | 2015-01-20 |
EA016814B1 (ru) | 2012-07-30 |
KR20080037676A (ko) | 2008-04-30 |
NO20080839L (no) | 2008-02-18 |
HK1160126A1 (en) | 2012-08-10 |
ZA200800303B (en) | 2009-01-28 |
CN101268051B (zh) | 2011-08-31 |
BRPI0614039A2 (pt) | 2011-03-09 |
NZ565078A (en) | 2010-03-26 |
AU2006274036A2 (en) | 2008-03-20 |
JP2009502871A (ja) | 2009-01-29 |
IL188773A0 (en) | 2008-08-07 |
AU2006274036A1 (en) | 2007-02-01 |
CA2615670A1 (en) | 2007-02-01 |
MX2008000901A (es) | 2008-03-26 |
KR101358509B1 (ko) | 2014-02-05 |
JP5448448B2 (ja) | 2014-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200700192A1 (ru) | Производные фталазина в качестве ингибиторов parp | |
EA200700188A1 (ru) | Производные замещенного 2-алкилхиназолинона как ингибиторы parp | |
EA200970156A1 (ru) | Пиридизиноновые производные | |
EA200700185A1 (ru) | Производные хиназолиндиона в качестве ингибиторов parp | |
EA200802050A1 (ru) | Новые гетероарилзамещенные ариламинопиридиновые производные в качестве мек ингибиторов | |
EA200901124A1 (ru) | Соединения формулы (i) в качестве ингибиторов серинпротеазы | |
EA200870116A1 (ru) | Бициклические гетероарильные соединения | |
EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
NO20073788L (no) | Kjemiske forbindelser | |
EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
EA200700168A1 (ru) | Производные замещенной циклической мочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназы | |
DK1853602T3 (da) | Kemiske forbindelser | |
BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
EA201101699A1 (ru) | Синергетические фунгицидные смеси | |
EA200701799A1 (ru) | Транс-каротиноиды, синтез указанных каротиноидов, получение композиций и их применение | |
EA200601007A1 (ru) | 7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы | |
EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
EA200900613A1 (ru) | Спирокетоновые ингибиторы ацетил-коа-карбоксилаз | |
EA201000494A1 (ru) | Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4 | |
EA200701328A1 (ru) | Замещенные триазольные производные в качестве антагонистов окситоцина | |
EA201000329A1 (ru) | Циклические депсипептиды | |
EA201000550A1 (ru) | Производные тиазола | |
EA200870515A1 (ru) | Моноциклические гетероарильные соединения | |
EA200601279A1 (ru) | Пиперидинилкарбонилпирролидины и их применение в качестве агонистов меланокортина | |
EA200700400A1 (ru) | Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |